Health
Heart surgery trial finds LAA closure beneficial only for high-risk patients
The LAACS-2 trial found no significant overall reduction in stroke or transient ischemic attack.
Written by AI1 source2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
The LAACS-2 trial found no significant overall reduction in stroke or transient ischemic attack.
An exploratory analysis found a more favorable long-term quality-of-life trajectory with twice-daily radiation.
ODDESSI followed 494 people in England for two years after a mental-health crisis.
The Korean maker can now pursue UNICEF and other international procurement programs.
A Bristol-led trial found integrated online CBT lowered adult depression scores by 4.4 points after six months.
Regeneron’s drug targets FOP, which progressively locks patients’ limbs by causing bone to form in soft tissue.
Ten patients received about 100 million lab-grown heart cells during bypass surgery.
A clinical trial found chilled platelets worked as well as room-temperature units for up to 21 days.
Eve lets eligible wheelchair users with spinal cord injuries walk hands-free.